Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,893,311
+$6,119,104 QoQ
Shares Held
693,384
-4.7% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 159 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. RAPP ranks #33 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in RAPP

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,893,311 693,384
2026-03-31 $22,774,207 727,843
2025-12-31 $23,920,389 788,411
2025-09-30 $25,411,914 855,620
2025-06-30 $13,128,802 1,154,688
2025-03-31 $11,129,538 1,109,625
2024-12-31 $19,485,882 1,098,415
2024-09-30 $22,301,102 1,088,921
2024-06-30 $25,373,357 1,090,858